Small Cap Stocks To Follow Now – May 19th

Protagenic Therapeutics, AltC Acquisition, and Novavax are the three Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies whose market capitalization typically falls between about $250 million and $2 billion. Because these firms are smaller and often in earlier growth stages, their share prices can offer higher upside potential but also tend to be more volatile and risk-prone than larger, more established companies. Investors often include small caps in a diversified portfolio to capture growth opportunities that may not be available in large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.

PTIX stock traded up $10.84 during midday trading on Monday, hitting $13.87. The stock had a trading volume of 91,296,524 shares, compared to its average volume of 501,830. Protagenic Therapeutics has a 52 week low of $2.35 and a 52 week high of $26.18. The firm has a market capitalization of $8.17 million, a price-to-earnings ratio of -10.92 and a beta of 0.28. The stock has a 50-day simple moving average of $3.55 and a 200 day simple moving average of $5.54.

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

ALCC stock traded up $0.31 during trading on Monday, hitting $37.72. 18,870,151 shares of the stock traded hands, compared to its average volume of 723,393. AltC Acquisition has a one year low of $10.27 and a one year high of $18.80. The company has a 50 day simple moving average of $25.04 and a 200 day simple moving average of $27.59.

Novavax (NVAX)

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response.

NVAX stock traded up $1.12 during trading on Monday, hitting $7.85. The company had a trading volume of 77,380,616 shares, compared to its average volume of 7,404,634. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of -3.47, a PEG ratio of 2.85 and a beta of 3.21. Novavax has a 12 month low of $5.01 and a 12 month high of $23.86. The firm has a 50-day moving average price of $6.69 and a 200-day moving average price of $7.88.